REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
6,20 € ↓ -0,10 (-1,59%)
2026-06-02
CENA AKCJI
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership164,421 shares
Latest Disclosed Value $ 2,367,662
Barclays Plc ownership in RB0 / REGENXBIO Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 164,421 shares of REGENXBIO Inc. (DE:RB0) valued at $1,973,052 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 225,940 shares of REGENXBIO Inc.. This represents a change in shares of -27.23% during the quarter. The current value of the position is $1,019,410 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (RB0) in the form of stock options. The firm currently holds call options representing 26,800 of underlying shares valued at $385,920 USD and put options representing 26,800 of underlying shares valued at $385,920 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:RB0 / REGENXBIO Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F REGENXBIO COM 75901B107 164,421 -61,519 -27.23 2,368 8.58 0.0006
2026-03-31 2025-09-30 13F/A-3 REGENXBIO COM 75901B107 225,940 -13,595 -5.68 2,180 10.89 0.0005
2026-03-19 2025-09-30 13F/A-2 REGENXBIO COM 75901B107 116,024 -123,511 1,217 0.0003
2025-11-12 2025-09-30 13F REGENXBIO COM 75901B107 225,940 -13,595 2,180 0.0005
2026-02-27 2025-06-30 13F/A-2 REGENXBIO COM 75901B107 239,535 119,876 100.18 1,967 129.94 0.0005
2025-08-14 2025-06-30 13F/A-1 REGENXBIO COM 75901B107 239,535 119,876 2 0.0005
2025-08-13 2025-06-30 13F REGENXBIO COM 75901B107 239,535 119,876 2 0.0001
2026-03-17 2025-03-31 13F/A-1 REGENXBIO COM 75901B107 119,659 -7,406 -5.83 856 -12.93 0.0002
2025-05-15 2025-03-31 13F REGENXBIO COM 75901B107 119,659 -7,406 1 0.0002
2026-03-19 2024-12-31 13F/A-1 REGENXBIO COM 75901B107 127,065 11,041 9.52 982 -19.31 0.0003
2025-02-13 2024-12-31 13F REGENXBIO COM 75901B107 127,065 11,041 1 0.0003
2026-03-31 2024-09-30 13F/A-2 REGENXBIO COM 75901B107 116,024 67,948 141.33 1,217 116.55 0.0003
2024-11-19 2024-09-30 13F/A-1 REGENXBIO COM 75901B107 116,024 67,948 1 0.0003
2024-11-15 2024-09-30 13F REGENXBIO COM 75901B107 116,024 67,948 1 0.0001
2026-03-23 2024-06-30 13F/A-1 REGENXBIO COM 75901B107 48,076 -1,376 -2.78 562 -46.01 0.0002
2024-08-14 2024-06-30 13F REGENXBIO COM 75901B107 48,076 -1,376 1 0.0002
2026-03-24 2024-03-31 13F/A-1 REGENXBIO COM 75901B107 49,452 -62,552 -55.85 1,042 -48.21 0.0004
2024-05-15 2024-03-31 13F REGENXBIO COM 75901B107 49,452 -62,552 1 0.0004
2026-03-25 2023-12-31 13F/A-1 REGENXBIO COM 75901B107 112,004 30,197 36.91 2,010 49.33 0.0007
2024-02-15 2023-12-31 13F REGENXBIO COM 75901B107 112,004 30,197 2 0.0007
2026-03-26 2023-09-30 13F/A-1 REGENXBIO COM 75901B107 81,807 -8,468 -9.38 1,347 -25.39 0.0008
2023-11-07 2023-09-30 13F REGENXBIO COM 75901B107 81,807 -8,468 1 0.0008
2026-03-30 2023-06-30 13F/A-2 REGENXBIO COM 75901B107 90,275 23,527 35.25 1,805 42.95 0.0011
2023-09-20 2023-06-30 13F/A-1 REGENXBIO COM 75901B107 90,275 23,527 2 0.0011
2023-08-03 2023-06-30 13F REGENXBIO COM 75901B107 90,275 23,527 2 0.0011
2026-03-30 2023-03-31 13F/A-1 REGENXBIO COM 75901B107 66,748 -29,860 -30.91 1,262 -42.40 0.0006
2023-05-04 2023-03-31 13F REGENXBIO COM 75901B107 66,748 -29,860 1 0.0006
2026-03-30 2022-12-31 13F/A-1 REGENXBIO COM 75901B107 96,608 11,463 13.46 2,191 -2.62 0.0010
2023-02-13 2022-12-31 13F REGENXBIO COM 75901B107 96,608 11,463 2 0.0010
2022-11-03 2022-09-30 13F REGENXBIO COM 75901B107 85,145 70,215 470.29 2,250 509.76 0.0025
2022-08-12 2022-06-30 13F REGENXBIO COM 75901B107 14,930 -32,616 -68.60 369 -76.60 0.0002
2022-05-16 2022-03-31 13F REGENXBIO COM 75901B107 47,546 -19,827 -29.43 1,577 -28.42 0.0012
2022-02-23 2021-12-31 13F/A-1 REGENXBIO COM 75901B107 67,373 -256 -0.38 2,203 -22.29 0.0008
2022-02-14 2021-12-31 13F REGENXBIO COM 75901B107 67,373 -256 2,203 0.0002
2021-11-09 2021-09-30 13F REGENXBIO COM 75901B107 67,629 32,591 93.02 2,835 108.15 0.0013
2021-08-13 2021-06-30 13F REGENXBIO COM 75901B107 35,038 -35,460 -50.30 1,362 -43.37 0.0006
2021-05-13 2021-03-31 13F REGENXBIO COM 75901B107 70,498 29,944 73.84 2,405 30.71 0.0013
2021-02-11 2020-12-31 13F REGENXBIO COM 75901B107 40,554 -31,215 -43.49 1,840 -6.88 0.0010
2020-11-12 2020-09-30 13F REGENXBIO COM 75901B107 71,769 -17,194 -19.33 1,976 -39.66 0.0012
2020-08-12 2020-06-30 13F REGENXBIO COM 75901B107 88,963 -1,162 -1.29 3,275 12.23 0.0025
2020-05-13 2020-03-31 13F REGENXBIO COM 75901B107 90,125 -96,543 -51.72 2,918 -61.84 0.0023
2020-02-10 2019-12-31 13F REGENXBIO COM 75901B107 186,668 125,679 206.07 7,646 252.03 0.0042
2019-11-15 2019-09-30 13F/A-1 REGENXBIO COM 75901B107 60,989 -7,288 -10.67 2,172 -38.08 0.0014
2019-11-14 2019-09-30 13F REGENXBIO COM 75901B107 60,989 -7,288 2,172 502.1689
2019-08-14 2019-06-30 13F REGENXBIO COM 75901B107 68,277 -14,702 -17.72 3,508 -26.26 0.0021
2019-05-15 2019-03-31 13F REGENXBIO COM 75901B107 82,979 48,106 137.95 4,757 225.38 0.0033
2019-02-14 2018-12-31 13F REGENXBIO COM 75901B107 34,873 1,135 3.36 1,462 -42.60 0.0011
2018-11-14 2018-09-30 13F REGENXBIO COM 75901B107 33,738 15,860 88.71 2,547 98.67 0.0018
2018-08-14 2018-06-30 13F REGENXBIO COM 75901B107 17,878 -2,637 -12.85 1,282 108.79 0.0011
2018-05-15 2018-03-31 13F REGENXBIO COM 75901B107 20,515 4,837 30.85 614 17.85 0.0005
2018-02-14 2017-12-31 13F REGENXBIO COM 75901B107 15,678 3,317 26.83 521 28.01 0.0004
2017-11-14 2017-09-30 13F REGENXBIO COM 75901B107 12,361 2,440 24.59 407 107.65 0.0004
2017-08-14 2017-06-30 13F REGENXBIO COM 75901B107 9,921 5,429 120.86 196 127.91 0.0002
2017-05-15 2017-03-31 13F REGENXBIO COM 75901B107 4,492 -1,063 -19.14 86 -16.50 0.0001
2017-02-14 2016-12-31 13F REGENXBIO COM 75901B107 5,555 5,428 4,274.02 103 5,050.00 0.0001
2016-11-14 2016-09-30 13F REGENXBIO COM 75901B107 127 127 0.00 2 0.0000
2016-05-16 2016-03-31 13F REGENXBIO COM 75901B107 0 -108 -100.00 0 -100.00
2016-02-12 2015-12-31 13F REGENXBIO COM 75901B107 108 108 2 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F REGENXBIO OPT Call 26,800 25.23 386 86.89 n/a n/a n/a
2026-03-31 2025-09-30 13F/A REGENXBIO OPT Call 21,400 0.00 207 17.71 n/a n/a n/a
2025-11-12 2025-09-30 13F REGENXBIO OPT Call 21,400 207 n/a n/a n/a
2025-08-14 2025-06-30 13F/A REGENXBIO OPT Call 21,400 0 n/a n/a n/a
2026-02-27 2025-06-30 13F/A REGENXBIO OPT Call 21,400 0.00 176 14.38 n/a n/a n/a
2026-03-17 2025-03-31 13F/A REGENXBIO OPT Call 21,400 153 n/a n/a n/a
2025-05-15 2025-03-31 13F REGENXBIO OPT Call 21,400 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A REGENXBIO OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENXBIO OPT Call 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A REGENXBIO OPT Call 25,000 527 n/a n/a n/a
2024-05-15 2024-03-31 13F REGENXBIO OPT Call 25,000 1 n/a n/a n/a
2019-05-15 2019-03-31 13F REGENXBIO OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F REGENXBIO OPT Call 5,700 239 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F REGENXBIO OPT Put 26,800 25.23 386 86.89 n/a n/a n/a
2026-03-31 2025-09-30 13F/A REGENXBIO OPT Put 21,400 0.00 207 17.71 n/a n/a n/a
2025-11-12 2025-09-30 13F REGENXBIO OPT Put 21,400 207 n/a n/a n/a
2025-08-14 2025-06-30 13F/A REGENXBIO OPT Put 21,400 0 n/a n/a n/a
2026-02-27 2025-06-30 13F/A REGENXBIO OPT Put 21,400 0.00 176 14.38 n/a n/a n/a
2026-03-17 2025-03-31 13F/A REGENXBIO OPT Put 21,400 153 n/a n/a n/a
2025-05-15 2025-03-31 13F REGENXBIO OPT Put 21,400 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A REGENXBIO OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F REGENXBIO OPT Put 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A REGENXBIO OPT Put 25,000 527 n/a n/a n/a
2024-05-15 2024-03-31 13F REGENXBIO OPT Put 25,000 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.